-
Something wrong with this record ?
Sustained deficiency of mitochondrial complex I activity during long periods of survival after seizures induced in immature rats by homocysteic acid
J. Folbergrová, P. Ješina, R. Haugvicová, V. Lisý, J. Houštěk
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Excitatory Amino Acid Agonists pharmacology MeSH
- Aldehydes metabolism MeSH
- Time Factors MeSH
- Down-Regulation drug effects physiology MeSH
- Energy Metabolism drug effects physiology MeSH
- Epilepsy metabolism physiopathology MeSH
- Homocysteine analogs & derivatives toxicity MeSH
- Convulsants toxicity MeSH
- Rats MeSH
- Metabolic Networks and Pathways physiology MeSH
- Survival Rate MeSH
- Mitochondrial Diseases chemically induced metabolism physiopathology MeSH
- Mitochondria drug effects metabolism MeSH
- Disease Models, Animal MeSH
- Cerebral Cortex metabolism pathology physiopathology MeSH
- Animals, Newborn MeSH
- Oxidative Stress drug effects physiology MeSH
- Rats, Wistar MeSH
- Electron Transport Complex I drug effects metabolism MeSH
- Free Radical Scavengers pharmacology MeSH
- Tyrosine analogs & derivatives metabolism MeSH
- Seizures chemically induced metabolism physiopathology MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Our previous work demonstrated the marked decrease of mitochondrial complex I activity in the cerebral cortex of immature rats during the acute phase of seizures induced by bilateral intracerebroventricular infusion of dl-homocysteic acid (600 nmol/side) and at short time following these seizures. The present study demonstrates that the marked decrease ( approximately 60%) of mitochondrial complex I activity persists during the long periods of survival, up to 5 weeks, following these seizures, i.e. periods corresponding to the development of spontaneous seizures (epileptogenesis) in this model of seizures. The decrease was selective for complex I and it was not associated with changes in the size of the assembled complex I or with changes in mitochondrial content of complex I. Inhibition of complex I was accompanied by a parallel, up to 5 weeks lasting significant increase (15-30%) of three independent mitochondrial markers of oxidative damage, 3-nitrotyrosine, 4-hydroxynonenal and protein carbonyls. This suggests that oxidative modification may be most likely responsible for the sustained deficiency of complex I activity although potential role of other factors cannot be excluded. Pronounced inhibition of complex I was not accompanied by impaired ATP production, apparently due to excess capacity of complex I documented by energy thresholds. The decrease of complex I activity was substantially reduced by treatment with selected free radical scavengers. It could also be attenuated by pretreatment with (S)-3,4-DCPG (an agonist for subtype 8 of group III metabotropic glutamate receptors) which had also a partial antiepileptogenic effect. It can be assumed that the persisting inhibition of complex I may lead to the enhanced production of reactive oxygen and/or nitrogen species, contributing not only to neuronal injury demonstrated in this model of seizures but also to epileptogenesis.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12025453
- 003
- CZ-PrNML
- 005
- 20130129170137.0
- 007
- ta
- 008
- 120816s2010 enk f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.neuint.2009.11.011 $2 doi
- 035 __
- $a (PubMed)19931336
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Folbergrová, Jaroslava, $d 1932- $7 jn20000400705 $u Institute of Physiology, Academy of Sciences of the Czech Republic, vvi, Vídenská 1083, 142 20 Prague 4, Czech Republic. folbergr@biomed.cas.cz
- 245 10
- $a Sustained deficiency of mitochondrial complex I activity during long periods of survival after seizures induced in immature rats by homocysteic acid / $c J. Folbergrová, P. Ješina, R. Haugvicová, V. Lisý, J. Houštěk
- 520 9_
- $a Our previous work demonstrated the marked decrease of mitochondrial complex I activity in the cerebral cortex of immature rats during the acute phase of seizures induced by bilateral intracerebroventricular infusion of dl-homocysteic acid (600 nmol/side) and at short time following these seizures. The present study demonstrates that the marked decrease ( approximately 60%) of mitochondrial complex I activity persists during the long periods of survival, up to 5 weeks, following these seizures, i.e. periods corresponding to the development of spontaneous seizures (epileptogenesis) in this model of seizures. The decrease was selective for complex I and it was not associated with changes in the size of the assembled complex I or with changes in mitochondrial content of complex I. Inhibition of complex I was accompanied by a parallel, up to 5 weeks lasting significant increase (15-30%) of three independent mitochondrial markers of oxidative damage, 3-nitrotyrosine, 4-hydroxynonenal and protein carbonyls. This suggests that oxidative modification may be most likely responsible for the sustained deficiency of complex I activity although potential role of other factors cannot be excluded. Pronounced inhibition of complex I was not accompanied by impaired ATP production, apparently due to excess capacity of complex I documented by energy thresholds. The decrease of complex I activity was substantially reduced by treatment with selected free radical scavengers. It could also be attenuated by pretreatment with (S)-3,4-DCPG (an agonist for subtype 8 of group III metabotropic glutamate receptors) which had also a partial antiepileptogenic effect. It can be assumed that the persisting inhibition of complex I may lead to the enhanced production of reactive oxygen and/or nitrogen species, contributing not only to neuronal injury demonstrated in this model of seizures but also to epileptogenesis.
- 650 _2
- $a aldehydy $x metabolismus $7 D000447
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a novorozená zvířata $7 D000831
- 650 _2
- $a mozková kůra $x metabolismus $x patologie $x patofyziologie $7 D002540
- 650 _2
- $a konvulziva $x toxicita $7 D003292
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a down regulace $x účinky léků $x fyziologie $7 D015536
- 650 _2
- $a respirační komplex I $x účinky léků $x metabolismus $7 D042967
- 650 _2
- $a energetický metabolismus $x účinky léků $x fyziologie $7 D004734
- 650 _2
- $a epilepsie $x metabolismus $x patofyziologie $7 D004827
- 650 _2
- $a agonisté excitačních aminokyselin $x farmakologie $7 D018690
- 650 _2
- $a scavengery volných radikálů $x farmakologie $7 D016166
- 650 _2
- $a homocystein $x analogy a deriváty $x toxicita $7 D006710
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a metabolické sítě a dráhy $x fyziologie $7 D053858
- 650 _2
- $a mitochondrie $x účinky léků $x metabolismus $7 D008928
- 650 _2
- $a mitochondriální nemoci $x chemicky indukované $x metabolismus $x patofyziologie $7 D028361
- 650 _2
- $a oxidační stres $x účinky léků $x fyziologie $7 D018384
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a záchvaty $x chemicky indukované $x metabolismus $x patofyziologie $7 D012640
- 650 _2
- $a míra přežití $7 D015996
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a tyrosin $x analogy a deriváty $x metabolismus $7 D014443
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Ješina, Pavel $7 xx0102694
- 700 1_
- $a Haugvicová, Renata $7 xx0030584
- 700 1#
- $a Lisý, Václav. $7 xx0181582
- 700 1_
- $a Houštěk, Josef, $7 xx0030591 $d 1947-
- 773 0_
- $w MED00003485 $t Neurochemistry international $x 1872-9754 $g Roč. 56, č. 3 (2010), s. 394-403
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/19931336 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120816 $b ABA008
- 991 __
- $a 20130129170301 $b ABA008
- 999 __
- $a ok $b bmc $g 947495 $s 782799
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 56 $c 3 $d 394-403 $i 1872-9754 $m Neurochemistry international $n Neurochem Int $x MED00003485
- LZP __
- $a Pubmed-20120816/10/02